GET INVOLVED
EVENT DETAILS
DELEGATE INFORMATION
PARTNERS
WBR
|
|
|
About Our Sponsors
 |
Abbott is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years.
Throughout our 100+ year history, Abbott people have been driven by a constant goal: to advance medical science to help people live healthier lives. It’s part of our heritage. And, it continues to drive our work. Today, 65,000 Abbott employees around the world share the passion for "Turning Science Into Caring." It's a commitment to focusing on what matters most: life and the potential it holds when we are feeling our best. www.abbott.com |
|
 |
The Boehringer Ingelheim group is one of the world’s 15 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38, 900 employees. Since it was founded in 1885, this family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. For more information, please visit http://us.boehringer-ingelheim.com. |
|
 |
Dean & Company is a strategy consulting firm with a unique mix of both traditional business strategy work and a range of investing activities for large corporations, technology start-ups, and equity funds. We work with senior executives to dramatically improve and sustain their company's performance. Dean & Company has an established, highly successful track record in generating actionable and quantifiable results for our clients in the Life Sciences. These include a number of the largest global companies as well as emerging leaders in the Pharmaceuticals, Biotechnology, and Medical Devices & Technology industries. We additionally have developed specialized expertise in the Vaccines industry. The hallmark of our work in life sciences, as in other industries, is our ability to deliver highly quantitative, analytic-driven solutions to complex business problems and the development of practical, action-oriented recommendations and their associated measurable impact on the bottom-line. Our life sciences capabilities extend across the following industry challenges and issues: Licensing/Strategic Alliances/M&A Due Diligence, Portfolio/Life Cycle Management, Product Commercialization & Launch, Manufacturing & Distribution Strategy, Competitive Intelligence/Benchmarking, Marketing Strategy, Pricing & Reimbursement, R&D Productivity |
|
 |
Gerson Lehrman Group (GLG) manages the world’s leading expert network and provides software and services to support a marketplace for expertise. GLG's unparalleled network of leading expert consultants, known as the GLG CouncilsSM, includes more than 175,000 subject matter experts and many key opinion leaders (KOLs) who educate and provide insight to decision makers worldwide. Healthcare companies use GLG to accelerate business development research and gather superior market intelligence. GLG’s expertise reaches every sector of the healthcare industry, from the mid-sized and most specialized organizations to some of the largest pharmaceutical, biotechnology, healthcare services, and medical device and supply companies in the world.
Visit us at www.glgroup.com |
|
 |
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier, and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis, and many other conditions. Founded in 1876, Lilly now employs more than 41,000 people worldwide and markets its medicines in 143 countries. It has major research and development facilities in nine countries and manufacturing facilities in 13 countries - and also conducts clinical trials in more than 50 countries. Lilly is committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs. |
|
 |
Upsher-Smith is constantly looking for strong and trusted partnerships through licensing, joint ventures, profit sharing, co-development and comarketing arrangements.
Upsher-Smith has a wide U.S. distribution network, experienced sales force and established customer relationships within all customer segments. Looking to the future, Upsher-Smith is focused on:
- Building our current product pipeline
- Co-promoting and acquiring women’s health products ready for commercialization
- Developing, in licensing and acquiring CNS products focused primarily on treatments for epilepsy & Parkinson’s disease.
Upsher-Smith is committed to the development and growth of innovative products. Our focus is simple: Advancing pharmacotherapy. Improving life.™ |
|
|
